The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

As the staff of Elon Musk's Department of Government Efficiency (DOGE) makes headlines for moving fast and breaking things, a ...

EXCLUSIVE: Director Adam Volerich is poised to add to the canon of Christmas cinema with Drink and Be Merry, an indie dramedy ...

Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for ...

1 Psychedelic therapy ... assessing the impact of functional unblinding and minimising potential bias The management of trial-related adverse events and significant hazards, while also considering ...

UK psychedelic medicine specialist Beckley Psytech ... with buy-in from Prime Movers Labs, Adage Capital Management, Palo Santo, Delphi VC, Leafy Tunnel, Negev Capital, and existing investor ...

The book will be of particular interest, of course, to fans of the Grateful Dead, many of whom treasure any knowledge about ...

AGN Neuro is also pleased to announce that as part of being appointed the CRO, Validcare has agreed to invest US $170K in exchange for equity issued by AGN Neuro. The investment in AGN Neuro will be ...

Zauberpilzblog.com, a leading platform dedicated to psychoactive substances, is proud to announce its new initiative aimed at becoming a global hub for information on magic mushrooms and cannabis.

Oasis have made a big announcement to celebrate the 25th anniversary of their fourth studio album. Standing On The Shoulder ...

Despite the high quality of the presentations, overall sales appeared much slower on Material’s first day. Dealers, however, were overall positive and satisfied, with few sales closed by the ...